AKT3 and differentiated thyroid carcinoma: The up-regulation of miR-29a obviously decreased AKT3 expression, via directly binding to the 3′-UTR of AKT3, thereby suppressing PI3K/AKT pathway activation, which were involved in multiple cellular functions in papillary thyroid carcinoma (PTC) [83].